/
AVNS
$24.93-$0.02 (-0.08%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.2B
47M shares
52-week range
$9.30 – $25.49
97% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-11.44
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $652.3M | $697.6M | $714.8M | $744.6M | $684.1M | $673.3M | $687.8M | $701.2M |
| Cost of revenue | $261.4M | $295.4M | $324.2M | $364.7M | $289.9M | $293.6M | $306.5M | $352.2M |
| Gross profit | $390.9M | $402.2M | $390.6M | $379.9M | $394.2M | $379.7M | $381.3M | $349.0M |
| Gross margin | 59.9% | 57.7% | 54.6% | 51.0% | 57.6% | 56.4% | 55.4% | 49.8% |
| R&D | $41.8M | $37.7M | $34.9M | $32.3M | $30.6M | $27.2M | $26.2M | $23.1M |
| Operating income | $34.9M | −$5.4M | $70.9M | $86.8M | $41.9M | $65.0M | $40.0M | −$61.6M |
| EBITDA | $37.0M | −$12.1M | −$2.0M | $48.9M | $77.8M | $50.6M | −$345.6M | −$33.2M |
| Net income | $57.5M | −$45.9M | −$27.2M | $6.3M | $50.5M | −$61.8M | −$392.1M | −$67.9M |
| Net margin | 8.8% | -6.6% | -3.8% | 0.8% | 7.4% | -9.2% | -57.0% | -9.7% |
| EPS (diluted) | 1.22 | -0.96 | -0.57 | 0.13 | 1.07 | -1.33 | -8.53 | -1.46 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $710M | $1.00 | $1.00–$1.00 | 1 |
| 2027 | $740M | $1.25 | $1.25–$1.25 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Avanos Medical, Inc.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
www.avanos.com- Employees
- 2,287
- IPO / List date
- Oct 21, 2014
- HQ
- ALPHARETTA, GA
Held by traders on TradeandTell
No one on the platform currently holds AVNS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 78,500 | $907.5K |
| Bridgewater Associatesas of 2024-09-30 | 10,471 | $251.6K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2006-05-15 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded AVNS yet.
